ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Iodobenzene → 2-Phenethyl-1,4-bis-(toluene-4-sulfonyl)-piperazine

HRID 1350381
ノート
印刷プレビュー

反応式

HRID 1350381 の反応式
B1[CH:6]2[CH2:7][CH2:8][CH2:9][CH:2]1CC[CH2:5]2.[C:10]1([CH3:37])[CH:15]=[CH:14][C:13]([S:16]([N:19]2[CH2:24][CH2:23][N:22]([S:25]([C:28]3[CH:33]=[CH:32][C:31]([CH3:34])=[CH:30][CH:29]=3)(=[O:27])=[O:26])[CH2:21][C@@H:20]2[CH:35]=[CH2:36])(=[O:18])=[O:17])=[CH:12][CH:11]=1.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.IC1C=CC=CC=1.[OH-].[Na+]>C1COCC1.[Pd].C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1>[CH2:35]([CH:20]1[CH2:21][N:22]([S:25]([C:28]2[CH:33]=[CH:32][C:31]([CH3:34])=[CH:30][CH:29]=2)(=[O:27])=[O:26])[CH2:23][CH2:24][N:19]1[S:16]([C:13]1[CH:14]=[CH:15][C:10]([CH3:37])=[CH:11][CH:12]=1)(=[O:17])=[O:18])[CH2:36][C:5]1[CH:6]=[CH:7][CH:8]=[CH:9][CH:2]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

8

反応物 5

HCID 11575IodobenzeneHCID 11776TriphenylphosphineHCID 14798Sodium HydroxideHCID 789669-Borabicyclo(3.3.1)nonaneHCID 14612246(S)-1,4-bis(toluene-4-sulfonyl)-2-vinyl-piperazine

生成物 1

HCID 694865562-Phenethyl-1,4-bis-(toluene-4-sulfonyl)-piperazine収率 75%

試薬・触媒・溶媒 2

HCID 11979704Tetrakis(triphenylphosphine)palladium触媒HCID 8028Tetrahydrofuran溶媒

実験手順

Add 9-BBN (0.5 M THF solution, 13.7 mL, 6.85 mmol) to a 100 mL schlenk flask containing (S)-1,4-bis(toluene-4-sulfonyl)-2-vinyl-piperazine(0.96 g, 2.3 mmol) in THF (5 mL), at room temperature under nitrogen and stir. After 18 hours, treat the reaction with tetrakis(triphenylphosphine) palladium (53 mg, 0.046 mmol), triphenyl phosphine (94.6 mg, 0.36 mmol), iodiobenzene (0.703 g, 3.4 mmol) and 3N NaOH (2.8 mL, 8.4 mmol) and heat to reflux. After 24 hours, cool the reaction to room temperature, remove in vacuo the THF solvent, dilute the residue with CH2Cl2, wash with 1N HCl, brine, and dry over Na2SO4. Purification by flash chromatography twice (Gradient: Hexanes/CH2Cl2=50/50, to Hexanes/CH2Cl2/EtOAc=40/40/10), and recrystallization in MeOH gives 860 mg (75%) of the title compound: mass spectrum (electrospray): (m/z)=499.2 (M+1); 1H NMR (CDCl3): δ7.58–7.54 (m, 4H), 7.33–7.20 (m, 7H), 7.19–7.07 (m, 2H), 3.99 (m, 1H), 3.81–3.78 (m, 1H), 3.64–3.60 (m, 2H), 3.22 (dt, 1H, J=3.2 Hz, J=12.4 Hz), 2.57–2.41 (m, 2H), 2.41 (s, 3H), 2.33 (s, 3H), 2.33–2.20 (m, 2H), 2.03–1.98 (m, 1H), 1.75–1.63 (m, 1H).

後処理

  1. additiontreat
  2. temperatureheat to reflux
  3. waitAfter 24 hours
  4. temperaturecool
  5. customthe reaction to room temperature
  6. customremove in vacuo the THF solvent
  7. additiondilute the residue with CH2Cl2
  8. washwash with 1N HCl, brine
  9. dry with materialdry over Na2SO4
  10. customPurification
  11. customby flash chromatography twice (Gradient: Hexanes/CH2Cl2=50/50, to Hexanes/CH2Cl2/EtOAc=40/40/10), and recrystallization in MeOH

出典と根拠

ORDレコード
ord-a1f9ab8ea5f44ab892ea2e5898ea6d0a
出典データセット
uspto-grants-2007_05
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US07214673B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート